<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02782273</url>
  </required_header>
  <id_info>
    <org_study_id>1-4627</org_study_id>
    <nct_id>NCT02782273</nct_id>
  </id_info>
  <brief_title>Morphine Versus Ketorolac in Renal Colic</brief_title>
  <official_title>The Analgesic Effects of Morphine Versus Ketorolac in Renal Colic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loredana Ghinea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bucharest Emergency Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is prospective, double blinded, randomised controlled and has the purpose to
      compare the analgesic effects of ketorolac or morphine intravenous in renal colic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will take place in the Emergency Department of the Clinical Emergency Hospital
      Bucharest and will compare the analgesic effects of ketorolac tromethamine against morphine
      in renal colic.

      The patients will be randomised to receive either ketorolac 30 mg intravenous (diluted in 20
      ml of 0,9% saline) or morphine 0,1 mg/kg weight intravenous. A scale of 1-10 will be used for
      measuring the pain, and the effects of the treatment will be evaluated at 15 minutes and 30
      minutes from the administration of the drugs. After 30 minutes if there is no significant
      reduction of the pain a rescue therapy will be used : chlorhydrate drotaverine 40 mg,
      xilocaine 100 mg, both diluted in 100 ml saline and the other medication not used from the
      study (morphine or ketorolac tromethamine).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reducing the grade of pain</measure>
    <time_frame>15 minutes, 30 minutes</time_frame>
    <description>To see the reducing of the pain on a scale 1-10 at two time points</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of staying in emergency department</measure>
    <time_frame>30 minutes, 1 hour, 2 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The necessity of urology consult - interventional measures</measure>
    <time_frame>7 days</time_frame>
    <description>The patients will be called after 7 days to see if they needed urology consult and urological intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The cost of each treatment</measure>
    <time_frame>1 hour</time_frame>
    <description>To evaluate the costs of treatment of each type of drug and/or rescue therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The necessity to use rescue therapy - pain &gt; 5 grade</measure>
    <time_frame>30 minutes</time_frame>
    <description>30 minutes from presentation in the ED - if the pain is still &gt; 5 on a 1-10 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects of each treatment</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Renal Colic</condition>
  <arm_group>
    <arm_group_label>Ketorolac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients randomised to this arm they will receive 30 mg intravenous ketorolac.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients randomised to this arm they will receive 0,1 mg/kg intravenous morphine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac</intervention_name>
    <description>The patients randomised to this arm they will receive 30 mg intravenous ketorolac.</description>
    <arm_group_label>Morphine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>The patients randomised to this arm they will receive 0,1 mg/kg intravenous morphine.</description>
    <arm_group_label>Ketorolac</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of renal colic

          -  grade 5 pain on a 1-10 visual pain scale

        Exclusion Criteria:

          -  contraindications of ketorolac or opioids

          -  pregnancy

          -  allergies to ketorolac or opioids

          -  refusal of participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Marinescu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Emergency Hospital Bucharest</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dan Marinescu, MD</last_name>
    <phone>0040741020848</phone>
    <email>danvmarinescu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Loredana Ghinea, MD</last_name>
    <phone>0040740694284</phone>
    <email>loredana.ghinea@gmail.com</email>
  </overall_contact_backup>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2016</study_first_submitted>
  <study_first_submitted_qc>May 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2016</study_first_posted>
  <last_update_submitted>May 24, 2016</last_update_submitted>
  <last_update_submitted_qc>May 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Bucharest Emergency Hospital</investigator_affiliation>
    <investigator_full_name>Loredana Ghinea</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>ketorolac</keyword>
  <keyword>pain relieve</keyword>
  <keyword>morphine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colic</mesh_term>
    <mesh_term>Renal Colic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

